Scinai Immunotherapeutics Ltd. (SCNI)
0.4844
+0.04
(+9.84%)
USD |
NASDAQ |
Nov 09, 16:00
0.479
-0.01
(-1.11%)
After-Hours: 19:29
Scinai Immunotherapeutics Price to Book Value : 0.1288 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.1173 |
| November 05, 2026 | 0.12 |
| November 04, 2026 | 0.1194 |
| November 03, 2026 | 0.1255 |
| November 02, 2026 | 0.1261 |
| October 30, 2026 | 0.1255 |
| October 29, 2026 | 0.1379 |
| October 28, 2026 | 0.1421 |
| October 27, 2026 | 0.1413 |
| October 26, 2026 | 0.144 |
| October 23, 2026 | 0.1502 |
| October 22, 2026 | 0.1625 |
| October 21, 2026 | 0.1623 |
| October 20, 2026 | 0.1812 |
| October 19, 2026 | 0.1995 |
| October 16, 2026 | 0.2001 |
| October 15, 2026 | 0.2398 |
| October 14, 2026 | 0.2341 |
| October 13, 2026 | 0.3272 |
| October 12, 2026 | 0.3086 |
| October 09, 2026 | 0.3139 |
| October 08, 2026 | 0.3219 |
| October 07, 2026 | 0.3006 |
| October 06, 2026 | 0.3245 |
| October 05, 2026 | 0.3352 |
| Date | Value |
|---|---|
| October 02, 2026 | 0.3538 |
| October 01, 2026 | 0.3485 |
| September 30, 2026 | 0.3777 |
| September 29, 2026 | 0.1316 |
| September 28, 2026 | 0.1372 |
| September 25, 2026 | 0.1447 |
| September 24, 2026 | 0.1737 |
| September 23, 2026 | 0.1849 |
| September 22, 2026 | 0.1783 |
| September 21, 2026 | 0.1578 |
| September 18, 2026 | 0.1457 |
| September 17, 2026 | 0.1513 |
| September 16, 2026 | 0.1419 |
| September 15, 2026 | 0.1438 |
| September 14, 2026 | 0.2278 |
| September 11, 2026 | 0.155 |
| September 10, 2026 | 0.1559 |
| September 09, 2026 | 0.1597 |
| September 08, 2026 | 0.1587 |
| September 04, 2026 | 0.1737 |
| September 03, 2026 | 0.1821 |
| September 02, 2026 | 0.2185 |
| September 01, 2026 | 0.2297 |
| August 31, 2026 | 0.2334 |
| August 28, 2026 | 0.2343 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Compugen Ltd. | 2.274 |
| Pluri, Inc. | -- |
| Evogene Ltd. | -- |
| CollPlant Biotechnologies Ltd. | 2.016 |
| Regentis Biomaterials Ltd. | -- |
Price to Book Value Related Metrics
| PE Ratio | 0.0167 |
| PS Ratio | 0.0258 |
| Price | 0.4844 |
| Earnings Yield | 5.97K% |
| Market Cap | 0.2761M |